Something changed in antibody discovery that the field spent a decade waiting for. Antibodies designed on a computer, rather than fished from an immunized animal or a display library, are now being validated in the lab at binding rates and affinities that hold their own against molecules found the traditional way. What was a promising…
Shots:
AI is revolutionizing healthcare, reshaping drug discovery, protein design, and precision therapeutics. Companies are now tackling previously “undruggable” targets and moving treatments through development pipelines faster than ever
The AI in the healthcare market is exploding. From a valuation of $26.57B in 2024, it is projected to reach $505.59B by 2033, growing at a CAGR of 38.8%. This rapid…

